Dr. Prasad Raje joined LGM Pharma as CEO in 2018 with the goal of growing the organization to better serve LGM’s customers. With leadership experience across analytical testing laboratories, drug substance, and drug product, he has overseen LGM’s expansion from a leading API sourcing organization for global pharmaceutical companies to an end-to-end contract development and manufacturing organization (CDMO) featuring: a network of prequalified API manufacturers, well over 100,000 square feet of U.S.-based development and manufacturing facilities and equipment, and expert regulatory and analytical testing services. Born and raised in India and educated in India and the U.S., Prasad’s extensive pharmaceutical career includes consulting and leadership roles at both large and small public and private organizations. Most recently, he was president, CEO, and board member of Nanotherapeutics, Inc.; senior vice president and head of the life sciences division at EAG Laboratories; vice president of development and manufacturing at Cambridge Major Laboratories (now Alcami); president of Smithers Pharma Services; and EVP and managing director of Smithers Viscient Laboratories. Prior to that, he held several roles at AMRI Global, leading up to serving as president and managing director at AMRI India. He earned his Ph.D. in organic chemistry at Auburn University.
.svg)
